Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury

View source ↗

Summary

The Expanded Access IND for Hope Biosciences' autologous adipose-derived mesenchymal stem cells for spinal cord injury is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Spinal Cord Injuries | Status: NO_LONGER_AVAILABLE